2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 142 filers reported holding 2SEVENTY BIO INC in Q1 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $168 | -86.5% | 43,118 | -64.9% | 0.00% | -100.0% |
| Q2 2023 | $1,244 | -69.1% | 122,778 | -68.8% | 0.00% | -50.0% |
| Q1 2023 | $4,021 | +456.9% | 394,126 | +411.8% | 0.00% | – |
| Q4 2022 | $722 | -99.9% | 77,002 | -7.6% | 0.00% | -100.0% |
| Q3 2022 | $1,213,000 | +2105.5% | 83,334 | +1914.8% | 0.00% | – |
| Q2 2022 | $55,000 | -38.9% | 4,136 | -21.4% | 0.00% | – |
| Q1 2022 | $90,000 | – | 5,265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 819,672 | $10,820,000 | 4.13% |
| Madison Avenue Partners, LP | 1,511,300 | $19,949,000 | 4.08% |
| Newtyn Management, LLC | 1,346,796 | $17,778,000 | 3.37% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $18,597,000 | 2.18% |
| EcoR1 Capital, LLC | 3,495,943 | $46,146,000 | 1.59% |
| Casdin Capital, LLC | 614,754 | $8,115,000 | 0.69% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $3,960,000 | 0.60% |
| Birchview Capital, LP | 59,833 | $790,000 | 0.58% |
| CAAS CAPITAL MANAGEMENT LP | 699,136 | $9,229,000 | 0.46% |
| Altium Capital Management LP | 83,000 | $1,096,000 | 0.44% |